All material subject to strictly enforced copyright laws. © 2022 Euromoney Institutional Investor PLC group
EquityEquity IPOs

BofA and UBS to lead Sandoz spin-off from Novartis

A logo sign outside of a facility occupied by Novartis in Vienna, Austria, on September 5, 2018.

The Swiss medical company said it opted for a direct listing for tax purposes

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Take a Free Trial or Login
We use cookies to provide a personalized site experience.
By continuing to use & browse the site you agree to our Privacy Policy.
I agree